Back

Association of ticagrelor vs clopidogrel with net adverse clinical events in STEMI patients with mild thrombocytopenia

1 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease: from bench to bedside (2) Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

6 More presentations in this session

Presentation thumbnail
Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II
Doctor T. Gu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial
Ms M. Lin (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Exploring the long-term effects of dapagliflozin in patients with stable acute myocardial infarction and preserved ejection fraction through a propensity score matching study
Doctor B. Hsiao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials
Professor J. Carson (New Brunswick, US)
Abstract Slides Video
Presentation thumbnail
CSWT improves ventricular function by promoting angiogenesis through Rho/ROCK/ERK1/2 signal pathway in infarcted myocardium in rats
Professor Y. Wang (Kunming, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in coronary artery disease: from bench to bedside (2)

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Association of ticagrelor vs clopidogrel with net adverse clinical events in NSTEMI patients with mild thrombocytopenia
thumbnail
Congress Presentation
Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with mild thrombocytopenia undergoing PCI
thumbnail
Congress Presentation
Ticagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources